Disability

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to...

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Data from 250-patient, 31-center, randomized controlled trial presented at European Stroke Organisation Conference Three highest enrolling sites reported 96% delivery...

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

accessiBe Forms Advisory Board and Testing Hub Comprised of Community Leaders and Disability Advocates to Drive Web Accessibility Product Innovation

Advisory Groups Launch on Global Accessibility Awareness Day (GAAD) NEW YORK, May 15, 2025 /PRNewswire/ -- Web accessibility market leader accessiBe,...

CEFALY to Demonstrate Its Migraine Treatment Device at the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting

DARIEN, Conn., May 13, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology will be conducting live demonstrations of its clinically...

Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes...

MIB acquires Clareto, forming strategic partnership with Munich Re Life US to expand access to electronic medical data and develop advanced data analytics

BRAINTREE, Mass. and NEW YORK, May 2, 2025 /PRNewswire/ -- MIB, the life insurance industry's most trusted and secure partner for...

error: Content is protected !!